PAREXEL's picture


Over the past 30 years, PAREXEL has developed significant expertise to assist clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products in order to bring safe and effective treatments to the global marketplace for the patients who need them. Headquartered near Boston, Massachusetts, PAREXEL operates over 78 locations throughout more than 52 countries around the world, and has over 14,400 employees.

We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.

PAREXEL press release, blog etc

09/20/2018 - 23:00 World Alzheimers Day: Reflecting on Progress and a Need for Collaboration Among Patients, Caregivers and the Drug Development Industry to Advance New Treatments
09/17/2018 - 04:31 Interview: Jason Martin, PAREXEL Corporate Vice President, Global Data Operations, and Travis May, Datavant co-founder and CEO
08/24/2018 - 16:36 HORIZONS 2018: Balancing Regulatory Compliance and Technology Innovation in Drug Development
08/08/2018 - 15:05 Balancing Regulatory Compliance and Technology Innovation in Drug Development
07/09/2018 - 16:40 Industry Experts Gather at PAREXEL for 2018 ISPE Investigational Products Community of Practice Symposium
06/26/2018 - 18:21 The increasingly important role of RWE in CE modeling
06/11/2018 - 08:27 Communicating Product Value for Success: Every Word Counts
06/11/2018 - 07:08 Increased Internal Collaboration is a Prerequisite for Improved Value Communication
04/25/2018 - 15:21 The Evolution of Randomization and Trial Supply Management Services
04/17/2018 - 14:28 PAREXEL Academy Introduces New Collaboration to Develop Japans Biopharmaceutical Workforce of the Future
03/13/2018 - 10:51 Exploring Our Partnership with CHA Medical Group
03/07/2018 - 13:32 Your clinical trial supply may be at risk Brexit and the impact on IMP distribution
03/01/2018 - 11:58 Generating Evidence to Drive Patient Access
02/14/2018 - 11:23 The Life of a Human Biological Sample: A Look Inside and How to Maintain Its Integrity
02/12/2018 - 11:44 Precision Medicines Next Hurdle: Quality Management of Human Samples
02/02/2018 - 11:11 World Cancer Day: Breakthroughs and Challenges for Precision Medicine
02/01/2018 - 08:13 Youre Hot Then Youre Cold -Temperature Management & RTSM Integration
02/01/2018 - 08:12 Aligning on Patient Outcomes How Market Dynamics Can Facilitate RWD (Real World Data) Solutions in Research